Page last updated: 2024-08-21

fluorobenzenes and Takotsubo Cardiomyopathy

fluorobenzenes has been researched along with Takotsubo Cardiomyopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, W; Hayashi, M; Ito, T; Izawa, H; Kamada, T; Mukaide, D; Ozaki, Y; Sugishita, Y; Yokoi, H; Yoshikawa, D; Yoshinaga, M1
E Madias, J1

Other Studies

2 other study(ies) available for fluorobenzenes and Takotsubo Cardiomyopathy

ArticleYear
Takotsubo cardiomyopathy with involvement of delayed-onset rhabdomyolysis and acute kidney injury after rosuvastatin treatment.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:1

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Diagnosis, Differential; Electrocardiography; Fluorobenzenes; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; Takotsubo Cardiomyopathy; Treatment Outcome; Withholding Treatment

2015
Persistent Excessive Electrocardiogram ST-segment Elevation in a Patient with a Takotsubo Syndrome: What Could be the Cause?
    Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:3

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Sulfonamides; Takotsubo Cardiomyopathy

2016